Auxergen Inc. Snags Presentation Slot at BIO International 2024 Convention
San Diego, California – March 18, 2024
Auxergen Inc., an innovator in biotechnology based in Maryland, proudly announces its selection for a coveted presentation slot at the esteemed BIO International Convention 2024, happening from June 3-6 at the San Diego Convention Center. This event, known as the world’s largest gathering for the biotechnology industry, brings together over 20,000 professionals from across the globe, including industry leaders in agriculture, healthcare, and environmental protection. Auxergen will be officially representing the state of Maryland:
Company Overview
Auxergen Inc. specializes in developing state-of-the-art biological solutions aimed at addressing significant challenges in agriculture, healthcare, and environmental protection. With a focus on phage-based technologies for sustainable agriculture and human cell-based assays for drug discovery. Auxergen is on a mission to create commercially viable applications that are rooted in responsible and sustainable science, fostering both scientific discovery and development.
Innovative Technologies and Achievements
Among Auxergen’s groundbreaking technologies are:
- AB-Phage: A topical treatment for combating antibiotic-resistant bacterial infections.
- XylePhage: A solution for Olive Quick Decline Syndrome and applications for grape vines and oleanders.
- CitriPhage / XanthaPhage: Innovative cures for citrus canker, rice blight, banana wilt and other major crop diseases.
- KataNase: A bio-antiviral for surface and personal protection.
- A Cannabinoid Bioactivity Assay tool for assessing the effects of cannabinoids on human cells.
Auxergen’s participation in the BIO International Convention 2024 is not just a milestone for the company but also a testament to the power of biotechnological innovation to address some of the most pressing issues facing our world today.
Media Contact:
Michael Feehley
michael@auxergen.com
443.929.9757
